BALPHARMA.BOBALPHARMA.BOBSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+46.7%
5Y CAGR+11.4%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+46.7%/yr
vs -9.2%/yr prior
5Y CAGR
+11.4%/yr
Recent acceleration
Acceleration
+56.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$81.24M+12.6%
2025$72.15M-2.4%
2024$73.92M+187.4%
2023$25.72M-54.2%
2022$56.12M+18.3%
2021$47.42M+138.8%
2020$-122.18M-422.6%
2019$37.88M+36.1%
2018$27.82M+40.1%
2017$19.86M-